Qualitative and Quantitative Changes in Coronary Plaque Associated With Atorvastatin Therapy

Abstract

In patients with CAD treated with atorvastatin, serial analysis with angioscopy demonstrated early loss of yellow color in plaques, and IVUS volumetric analysis showed subsequent plaque regression. Both changes possibly indicate reduction of plaque vulnerability in an additive manner.